Ureteroscopy outcomes drop in large lower-pole stones

The approval is supported by data from the phase 3 CheckMate-67T trial.

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia.

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

Test your knowledge of these often-overlooked but essential aspects of genetic and genomic testing.

The SURE procedure also demonstrated significantly better outcomes on the study’s secondary end points of stone clearance and residual stone volume.